A randomized controlled trial to compare Helicobacter pylori eradication rates between the empirical concomitant therapy and tailored therapy based on 23S rRNA point mutations

BACKGROUND: Increasing clarithromycin resistance has led to changes in several guidelines for treatment of Helicobacter pylori infections. We compared the H. pylori eradication rates of the empirical concomitant therapy (CoT) and a tailored therapy (TaT) using dual-priming oligonucleotide-based poly...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Su Jin, Jee, Sam Ryong, Park, Moo In, Jung, Kyoungwon, Kim, Gwang Ha, Lee, Moon Won, Lee, Jin, Jang, Jin Seok, Koh, Myeongseok
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387952/
https://www.ncbi.nlm.nih.gov/pubmed/35984159
http://dx.doi.org/10.1097/MD.0000000000030069

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9387952/
https://www.ncbi.nlm.nih.gov/pubmed/35984159
http://dx.doi.org/10.1097/MD.0000000000030069

Ejemplares similares